Injections for back pain

Orthobiologics therapy for back pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-3h484dp

Enrollment

Unknown

Registered

2021-11-24

Start date

2018-01-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Interventions

Experimental Group: 55 patients with low back pain without improvement with conservative treatment and indication for interventional procedure (blockage/spinal injection) will receive an injection of

E02.319.267.530.580

Eligibility

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Low back pain for more 12 weeks. Failure of conservative treatments (oral medications; physical therapy). Satisfy criteria for lumbar epidural; facet; intradiscal or paravertebral intramuscular injection.

Exclusion criteria

Exclusion criteria: Refusal to participate in research. Age younger than 18 year old or older than 80 year old. Active infection. Neoplasm. Conditions requiring surgery: cauda equina syndrome; spinal instability; progressive neurological deficit. Severe stenosis. Allergy to contrast material or local anesthesia. Presence of unstable psychiatric condition. Hematologic disorders: thrombocytopenia; coagulation disorders; sickle cell disease.

Design outcomes

Primary

Measure	Time frame
Relief of low back pain on the Visual Analog Scale is expected to be found in at least 30% of patients.	—

Secondary

Measure	Time frame
Secondary outcomes are not expected.	—

Countries

Brazil

Contacts

Public ContactEdison Machado

ortospine@gmail.com+55 51 35333320

Outcome results

None listed

Source: REBEC (via WHO ICTRP)